Business profile
Loading canonical business information.
About
Services
Products
Articles & research
Offers
Published by the business. Confirm current availability and terms with the business.
Browse productsPromotions
Published by the business. Confirm current availability and terms with the business.
Browse productsFrequently asked questions
Answers published by the business.
Published agent capabilities
Capabilities recorded in this listing. Their presence is not a live availability check.
AI-readable discovery
Read the structured business information and inspect the published discovery documents.
Machine-readable documents do not by themselves establish a live AI agent, checkout or business ownership.
Request a quote
Loading quote availability…
Sources
Report this listing
Tell us what needs reviewing. Removal requests are reviewed before any change is made.
Request removalProfile information
Publication, owner access and business registry verification are separate. Verification badges describe the checks completed; public references identify this listing.
Structured public business summary
Georgetown Law Technology Review
Georgetown Law Technology Review Georgetown Law Technology Review Home Masthead Issues Scholarship Articles Notes Essays Tech Explainers Legal Impressions Submissions Write-On Symposium Search for: Privacy, Power & Empowerment: How Period Trackers Fail to Protect Women Abigail Patchen Period-tracking applications occupy a large share of the FemTech industry, offering users intimate insights into their reproductive health while simultaneously exposing them to unprecedented privacy risks. Period-tracking apps regularly disseminate highly sensitive health data under the protection of the notice and consent paradigm of privacy law, an outdated framework that places the burden of privacy […] Read More AI in Pharmaceutical Research and Development: A Tiered Proposal Realigning Regulatory Exclusivity Periods Ingrid Villarreal This Note examines how artificial intelligence (“AI”) is fundamentally transforming pharmaceutical research and development (“R&D”), altering the cost, risk, and timelines that traditionally justify regulatory exclusivity protections. As AI-enabled technologies accelerate drug discovery and increase clinical success rates, the traditional assumptions supporting lengthy exclusivity periods are becoming less persuasive.
Global
Business nature
- Primary business nature
- Not provided
- Customer market
- Not provided
Operating hours
Hours not provided.
Categories
- Other Businesses & Services (primary)
Public contacts
- Public email: gltr@georgetown.edu
- Public phone: 2026-2027
- instagram: https://www.instagram.com/gulctechreview/
- linkedin: https://www.linkedin.com/company/gltr
Directory status
Registry verification: Not Registry Verified
Directory score: 74